Application 203826
- Type
- NDA
- Sponsor
- WEST WARD PHARM CORP
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | SOLUTION;INTRAVENOUS | 10MG/ML (10MG/ML) | Yes | Yes |
| 002 | PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | SOLUTION;INTRAVENOUS | 50MG/5ML (10MG/ML) | Yes | Yes |
| 003 | PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | SOLUTION;INTRAVENOUS | 100MG/10ML (10MG/ML) | Yes | Yes |
| 004 | IMMPHENTIV | PHENYLEPHRINE HYDROCHLORIDE | SOLUTION;INTRAVENOUS | 0.5MG/5ML (0.1MG/ML) | Yes | Yes |
| 005 | IMMPHENTIV | PHENYLEPHRINE HYDROCHLORIDE | SOLUTION;INTRAVENOUS | 1MG/10ML (0.1MG/ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N203826-001 | PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2012-12-20 |
| N203826-002 | PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 50MG/5ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2019-06-19 |
| N203826-003 | PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2019-06-19 |
| N203826-004 | IMMPHENTIV | PHENYLEPHRINE HYDROCHLORIDE | 0.5MG/5ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | |
| N203826-005 | IMMPHENTIV | PHENYLEPHRINE HYDROCHLORIDE | 1MG/10ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N203826-001 | AP2 |
| N203826-002 | AP2 |
| N203826-003 | AP2 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N203826-004 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | |
| N203826-004 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | |
| N203826-004 | 12257342 | 2036-09-26 | Drug product | 2025-04-23 | |
| N203826-005 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | |
| N203826-005 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | |
| N203826-005 | 12257342 | 2036-09-26 | Drug product | 2025-04-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N203826-001 | PHENYLEPHRINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2012-12-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N203826-002 | PHENYLEPHRINE HYDROCHLORIDE | 50MG/5ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2019-06-19 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N203826-003 | PHENYLEPHRINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2019-06-19 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N203826-004 | IMMPHENTIV | 0.5MG/5ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N203826-005 | IMMPHENTIV | 1MG/10ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-001 | PHENYLEPHRINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2012-12-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-002 | PHENYLEPHRINE HYDROCHLORIDE | 50MG/5ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2019-06-19 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-003 | PHENYLEPHRINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2019-06-19 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-004 | IMMPHENTIV | 0.5MG/5ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-005 | IMMPHENTIV | 1MG/10ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N203826-001 | PHENYLEPHRINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2012-12-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N203826-002 | PHENYLEPHRINE HYDROCHLORIDE | 50MG/5ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-06-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N203826-003 | PHENYLEPHRINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-06-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N203826-004 | IMMPHENTIV | 0.5MG/5ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N203826-005 | IMMPHENTIV | 1MG/10ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N203826-001 | PHENYLEPHRINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2012-12-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N203826-002 | PHENYLEPHRINE HYDROCHLORIDE | 50MG/5ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-06-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N203826-003 | PHENYLEPHRINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-06-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N203826-004 | IMMPHENTIV | 0.5MG/5ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N203826-005 | IMMPHENTIV | 1MG/10ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N203826-001 | PHENYLEPHRINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2012-12-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N203826-002 | PHENYLEPHRINE HYDROCHLORIDE | 50MG/5ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-06-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N203826-003 | PHENYLEPHRINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-06-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N203826-004 | IMMPHENTIV | 0.5MG/5ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N203826-005 | IMMPHENTIV | 1MG/10ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N203826-001 | PHENYLEPHRINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2012-12-20 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N203826-002 | PHENYLEPHRINE HYDROCHLORIDE | 50MG/5ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-06-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N203826-003 | PHENYLEPHRINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-06-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N203826-004 | IMMPHENTIV | 0.5MG/5ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N203826-005 | IMMPHENTIV | 1MG/10ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N203826-001 | PHENYLEPHRINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2012-12-20 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N203826-002 | PHENYLEPHRINE HYDROCHLORIDE | 50MG/5ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-06-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N203826-003 | PHENYLEPHRINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-06-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N203826-004 | IMMPHENTIV | 0.5MG/5ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N203826-005 | IMMPHENTIV | 1MG/10ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N203826-001 | PHENYLEPHRINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAVENOUS | AP2 | RLD, RS | 2012-12-20 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N203826-002 | PHENYLEPHRINE HYDROCHLORIDE | 50MG/5ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-06-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N203826-003 | PHENYLEPHRINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-06-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N203826-004 | IMMPHENTIV | 0.5MG/5ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N203826-005 | IMMPHENTIV | 1MG/10ML (0.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-03-09 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N203826-001 | AP2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N203826-002 | AP2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N203826-003 | AP2 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-001 | AP2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-002 | AP2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-003 | AP2 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N203826-001 | AP2 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N203826-001 | AP2 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N203826-001 | AP2 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N203826-001 | AP2 | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N203826-001 | AP2 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N203826-001 | AP2 | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N203826-001 | AP2 | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N203826-001 | AP2 | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N203826-001 | AP2 | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N203826-001 | AP2 | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N203826-001 | AP2 | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N203826-001 | AP2 | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N203826-001 | AP2 | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N203826-002 | AP2 | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N203826-003 | AP2 | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N203826-001 | AP2 | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N203826-002 | AP2 | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N203826-003 | AP2 | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N203826-001 | AP2 | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N203826-002 | AP2 | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N203826-003 | AP2 | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N203826-001 | AP2 | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N203826-002 | AP2 | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N203826-003 | AP2 | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N203826-001 | AP2 | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N203826-002 | AP2 | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N203826-003 | AP2 | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N203826-001 | AP2 | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N203826-002 | AP2 | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N203826-003 | AP2 | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N203826-001 | AP2 | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N203826-002 | AP2 | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N203826-003 | AP2 | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N203826-001 | AP2 | 1 | 5aa47cf7b7d7… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N203826-004 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N203826-004 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N203826-004 | 12257342 | 2036-09-26 | Drug product | 2025-04-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N203826-005 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N203826-005 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N203826-005 | 12257342 | 2036-09-26 | Drug product | 2025-04-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-004 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-004 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-004 | 12257342 | 2036-09-26 | Drug product | 2025-04-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-005 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-005 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N203826-005 | 12257342 | 2036-09-26 | Drug product | 2025-04-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N203826-004 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N203826-004 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N203826-004 | 12257342 | 2036-09-26 | Drug product | 2025-04-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N203826-005 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N203826-005 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N203826-005 | 12257342 | 2036-09-26 | Drug product | 2025-04-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N203826-004 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N203826-004 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N203826-005 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N203826-005 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N203826-004 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N203826-004 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N203826-005 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N203826-005 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N203826-004 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N203826-004 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N203826-005 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N203826-005 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N203826-004 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N203826-004 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N203826-005 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N203826-005 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N203826-004 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N203826-004 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N203826-005 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N203826-005 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N203826-004 | 11471400 | 2036-08-05 | Drug product | 2023-03-22 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N203826-004 | 11213480 | 2036-09-26 | Drug product | 2023-03-22 | d8e5a09893c0… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Civica, Inc. | 7a23ed28-3912-4398-b660-bf9ec3ee3926 | 2024-12-26 | Warnings, Adverse reactions | 203826 NDA203826 72572-570 72572-571 |
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | c3f358dd-4a36-4808-9943-e01f88604be5 | 2024-04-10 | Warnings, Adverse reactions | 203826 NDA203826 0641-6229 |
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | e1a7ab4b-0afe-4463-a039-5be0323cf2f7 | 2024-04-09 | Warnings, Adverse reactions | 203826 NDA203826 0641-6142 0641-6189 0641-6188 |
| PHENYLEPHRINE HCI | PHENYLEPHRINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 7602fb73-3ce3-5978-e053-2991aa0abea3 | 2024-02-22 | Warnings, Adverse reactions | 203826 NDA203826 51662-1249 |
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | d88a01c4-9681-2695-e053-2995a90a62ea | 2023-05-30 | Warnings, Adverse reactions | 203826 NDA203826 71872-7043 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0641-6142 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Hikma Pharmaceuticals USA Inc. | NDA | Current |
| 0641-6142 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | West-Ward Pharmaceuticals Corp. | NDA | Current |
| 0641-6142 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Hikma Pharmaceuticals USA Inc. | NDA | Current |
| 0641-6188 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Hikma Pharmaceuticals USA Inc. | NDA | Current |
| 0641-6188 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Hikma Pharmaceuticals USA Inc. | NDA | Current |
| 0641-6189 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Hikma Pharmaceuticals USA Inc. | NDA | Current |
| 0641-6189 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Hikma Pharmaceuticals USA Inc. | NDA | Current |
| 0641-6229 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Hikma Pharmaceuticals USA Inc. | NDA | Current |
| 0641-6229 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | West-Ward Pharmaceuticals Corp. | NDA | Current |
| 51662-1249 | PHENYLEPHRINE HCI | PHENYLEPHRINE HCI | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 51662-1249 | PHENYLEPHRINE HCI | PHENYLEPHRINE HCI | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 51662-1249 | PHENYLEPHRINE HCI | PHENYLEPHRINE HCI | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 51662-1249 | PHENYLEPHRINE HCI | PHENYLEPHRINE HCI | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 51662-1249 | PHENYLEPHRINE HCI | PHENYLEPHRINE HCI | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 52584-142 | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | General Injectables & Vaccines, Inc | NDA | Current |
| 52584-142 | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | General Injectables & Vaccines, Inc | NDA | Current |
| 55154-5129 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Cardinal Health | NDA | Current |
| 55154-5129 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Cardinal Health | NDA | Current |
| 70518-1038 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | REMEDYREPACK INC. | NDA | Current |
| 71872-7043 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Medical Purchasing Solutions, LLC | NDA | Current |
| 72572-570 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Civica, Inc. | NDA | Current |
| 72572-571 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Civica, Inc. | NDA | Current |